Press Releases SpectraCure AB

Equities

SPEC

SE0007158118

Market Closed - Nasdaq Stockholm Other stock markets 11:29:46 2024-04-29 am EDT			5-day change	1st Jan Change
2.67 ^SEK	-6.97%		+6.59%	-30.83%

Feb. 23	Spectracure AB Continues in the Process of Initiating A Clinical Study, for Primary Localised Prostate Cancer	CI
Feb. 22	SpectraCure AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SpectraCure takes the next step in the work with the new clinical study	Feb. 23	AQ
A well-accomplished annual audit in accordance with ISO 13485:2016	Jan. 23	AQ
Expert group comments on results of ongoing study	Dec. 19	AQ
SpectraCure : Masoud Khayyami presents SpectraCure at investor meetingon November 5 in Lund!	Nov. 29	PU
SpectraCure has decided to seek approval for a clinical study of primary prostate cancer	Nov. 16	AQ
SpectraCure : Meet SpectraCure’s board member, Homer Pien!	23-10-31	PU
SpectraCure strengthens presence among urologists	23-10-06	AQ
SpectraCure has been awarded an additional EU grant for industrialisation of the company's treatment system Q-PRO®	23-06-27	AQ
SpectraCures signs Letter of Intent with Cheplapharm	22-12-07	AQ
SpectraCure : First treatment with Q-PRO and integrated image management technology	22-11-24	PU
SpectraCure : Skåne University Hospital in Malmö is included in the clinical trial for treatment of recurrent prostate cancer	22-11-23	PU
SpectraCure : new treatment system has been approved in the UK for use in clinical trials	22-09-18	PU
Patent regarding the new generation of treatment systems approved in Europe	22-08-30	AQ
SpectraCure : Software for improved imaging technology is approved for use in clinical study in the US	22-06-19	PU
SpectraCure has been approved a grant from EU of € 125,000	22-06-07	AQ
SpectraCure : Patent approved in Europe	22-06-02	PU
A new Board has been installed at SpectraCure	22-05-16	AQ
SpectraCure : Investor Letter July 2021	21-07-12	PU
SpectraCure : The Nomination Committee's proposal for election of board members in SpectraCure AB	21-04-15	AQ
SpectraCure : Status update regarding clinical studies for the treatment of patients with recurrent prostate cancer	21-03-05	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases SpectraCure AB

Equities

SPEC

SE0007158118

Press Releases

Filters